219 related articles for article (PubMed ID: 19897029)
1. Congenital anomalies, labor/delivery complications, maternal risk factors and their relationship with perfluorooctanoic acid (PFOA)-contaminated public drinking water.
Nolan LA; Nolan JM; Shofer FS; Rodway NV; Emmett EA
Reprod Toxicol; 2010 Apr; 29(2):147-55. PubMed ID: 19897029
[TBL] [Abstract][Full Text] [Related]
2. The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water.
Nolan LA; Nolan JM; Shofer FS; Rodway NV; Emmett EA
Reprod Toxicol; 2009 Jun; 27(3-4):231-238. PubMed ID: 19049861
[TBL] [Abstract][Full Text] [Related]
3. Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community.
Savitz DA; Stein CR; Bartell SM; Elston B; Gong J; Shin HM; Wellenius GA
Epidemiology; 2012 May; 23(3):386-92. PubMed ID: 22370857
[TBL] [Abstract][Full Text] [Related]
4. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley.
Steenland K; Zhao L; Winquist A; Parks C
Environ Health Perspect; 2013 Aug; 121(8):900-5. PubMed ID: 23735465
[TBL] [Abstract][Full Text] [Related]
5. Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts.
Winquist A; Steenland K
Epidemiology; 2014 Mar; 25(2):255-64. PubMed ID: 24407430
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome.
Stein CR; Savitz DA; Dougan M
Am J Epidemiol; 2009 Oct; 170(7):837-46. PubMed ID: 19692329
[TBL] [Abstract][Full Text] [Related]
7. Private drinking water wells as a source of exposure to perfluorooctanoic acid (PFOA) in communities surrounding a fluoropolymer production facility.
Hoffman K; Webster TF; Bartell SM; Weisskopf MG; Fletcher T; Vieira VM
Environ Health Perspect; 2011 Jan; 119(1):92-7. PubMed ID: 20920951
[TBL] [Abstract][Full Text] [Related]
8. Relationship of perfluorooctanoic acid exposure to pregnancy outcome based on birth records in the mid-Ohio Valley.
Savitz DA; Stein CR; Elston B; Wellenius GA; Bartell SM; Shin HM; Vieira VM; Fletcher T
Environ Health Perspect; 2012 Aug; 120(8):1201-7. PubMed ID: 22450153
[TBL] [Abstract][Full Text] [Related]
9. Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure.
Barry V; Darrow LA; Klein M; Winquist A; Steenland K
Environ Res; 2014 Jul; 132():62-9. PubMed ID: 24742729
[TBL] [Abstract][Full Text] [Related]
10. Perfluorooctanoate exposure and major birth defects.
Stein CR; Savitz DA; Elston B; Thorpe PG; Gilboa SM
Reprod Toxicol; 2014 Aug; 47():15-20. PubMed ID: 24803403
[TBL] [Abstract][Full Text] [Related]
11. Association between maternal exposure to perfluorooctanoic acid (PFOA) from electronic waste recycling and neonatal health outcomes.
Wu K; Xu X; Peng L; Liu J; Guo Y; Huo X
Environ Int; 2012 Nov; 48():1-8. PubMed ID: 22820015
[TBL] [Abstract][Full Text] [Related]
12. Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community.
Seals R; Bartell SM; Steenland K
Environ Health Perspect; 2011 Jan; 119(1):119-24. PubMed ID: 20870569
[TBL] [Abstract][Full Text] [Related]
13. Occurrence and potential significance of perfluorooctanoic acid (PFOA) detected in New Jersey public drinking water systems.
Post GB; Louis JB; Cooper KR; Boros-Russo BJ; Lippincott RL
Environ Sci Technol; 2009 Jun; 43(12):4547-54. PubMed ID: 19603675
[TBL] [Abstract][Full Text] [Related]
14. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives.
Olsen GW; Butenhoff JL; Zobel LR
Reprod Toxicol; 2009 Jun; 27(3-4):212-230. PubMed ID: 19429401
[TBL] [Abstract][Full Text] [Related]
15. Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia.
Bartell SM; Calafat AM; Lyu C; Kato K; Ryan PB; Steenland K
Environ Health Perspect; 2010 Feb; 118(2):222-8. PubMed ID: 20123620
[TBL] [Abstract][Full Text] [Related]
16. Design, methods, and population for a study of PFOA health effects among highly exposed mid-Ohio valley community residents and workers.
Winquist A; Lally C; Shin HM; Steenland K
Environ Health Perspect; 2013 Aug; 121(8):893-9. PubMed ID: 23735518
[TBL] [Abstract][Full Text] [Related]
17. Modeled Perfluorooctanoic Acid (PFOA) Exposure and Liver Function in a Mid-Ohio Valley Community.
Darrow LA; Groth AC; Winquist A; Shin HM; Bartell SM; Steenland K
Environ Health Perspect; 2016 Aug; 124(8):1227-33. PubMed ID: 26978841
[TBL] [Abstract][Full Text] [Related]
18. Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations.
Worley RR; Yang X; Fisher J
Toxicol Appl Pharmacol; 2017 Sep; 330():9-21. PubMed ID: 28684146
[TBL] [Abstract][Full Text] [Related]
19. Relation between perfluorooctanoic acid exposure and strokes in a large cohort living near a chemical plant.
Simpson C; Winquist A; Lally C; Steenland K
Environ Res; 2013 Nov; 127():22-8. PubMed ID: 24199934
[TBL] [Abstract][Full Text] [Related]
20. Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant.
Steenland K; Tinker S; Frisbee S; Ducatman A; Vaccarino V
Am J Epidemiol; 2009 Nov; 170(10):1268-78. PubMed ID: 19846564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]